InsidersTradesSigma
Track the Clearmind Medicine Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Market capitalisation: €3.5m. The latest transaction was reported on 18 June 2026 (Cession). Among the most active insiders: HRT FINANCIAL LP. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
Clearmind Medicine Inc. is a biopharmaceutical company focused on developing treatments for mental health disorders. It specializes in the use of psychedelic medicine to enhance mental well-being.